Contract facts
UnrestrictedNo full NAICS 541940 intel page yet. Browse NAICS intelligence
Histopathology Services to Support 5 Efficacy Studies Starting with Prepared Slides and 5 Studies Starting with Fixed T… is a federal Unrestricted award for National Institutes Of Health Niaid held by Experimental Pathology Laboratories, Inc. Estimated value $218K ($130K obligated). Current period of performance ends Mar 24, 2027 (potential Sep 24, 2027). Last award drew 6 bidders. Place of performance: STERLING VA. Related solicitation RFQ-NIAID-24-2226993.
Histopathology services to support 5 efficacy studies starting with prepared slides and 5 studies starting with fixed tissues. options for additional studies starting with prepared slides as well as studies starting with fixed tissues. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Mar 24, 2027 (158 days remaining). Agencies typically plan 12–18 months ahead — at 5.2 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N93024P01204? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordExperimental Pathology Laboratories, Inc — $22.2M obligated across 18 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93024P01204?
75N93024P01204 (Histopathology services to support) is a National Institutes Of Health Niaid award with a potential value of $218K, currently held by Experimental Pathology Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93024P01204?
National Institutes Of Health Niaid awarded 75N93024P01204 to Experimental Pathology Laboratories, Inc (potential $218K).
Who is the incumbent on 75N93024P01204?
Experimental Pathology Laboratories, Inc is the incumbent with $22.2M across 18 related awards in SCOUT’s public footprint. The current period of performance ends Mar 24, 2027.
When does Experimental Pathology Laboratories, Inc’s 75N93024P01204 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N93024P01204? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.